These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 23235720)

  • 1. Differences in CD44s expression in HNSCC tumours of different areas within the oral cavity.
    Krump M; Ehrmann J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2013 Dec; 157(4):280-3. PubMed ID: 23235720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of hyaluronan synthase 2 to promote CD44-dependent oral cavity squamous cell carcinoma progression.
    Wang SJ; Earle C; Wong G; Bourguignon LY
    Head Neck; 2013 Apr; 35(4):511-20. PubMed ID: 22473523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The potential of CD44 as a diagnostic and prognostic tool in oral cancer.
    Emich H; Chapireau D; Hutchison I; Mackenzie I
    J Oral Pathol Med; 2015 Jul; 44(6):393-400. PubMed ID: 25640063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic markers in stage I oral cavity squamous cell carcinoma.
    Dunkel J; Vaittinen S; Grénman R; Kinnunen I; Irjala H
    Laryngoscope; 2013 Oct; 123(10):2435-41. PubMed ID: 23918741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in p63 expression in SCCHN tumours of different sub-sites within the oral cavity.
    Boldrup L; Coates PJ; Laurell G; Nylander K
    Oral Oncol; 2011 Sep; 47(9):861-5. PubMed ID: 21802344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of site-specific prognosis of cancer stem cell marker CD44 in head and neck squamous-cell carcinoma.
    Kokko LL; Hurme S; Maula SM; Alanen K; Grénman R; Kinnunen I; Ventelä S
    Oral Oncol; 2011 Jun; 47(6):510-6. PubMed ID: 21514878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD44s and CD44v6 expression in head and neck epithelia.
    Mack B; Gires O
    PLoS One; 2008; 3(10):e3360. PubMed ID: 18852874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD44(high) /ALDH1(high) head and neck squamous cell carcinoma cells exhibit mesenchymal characteristics and GSK3β-dependent cancer stem cell properties.
    Seino S; Shigeishi H; Hashikata M; Higashikawa K; Tobiume K; Uetsuki R; Ishida Y; Sasaki K; Naruse T; Rahman MZ; Ono S; Simasue H; Ohta K; Sugiyama M; Takechi M
    J Oral Pathol Med; 2016 Mar; 45(3):180-8. PubMed ID: 26399460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD44 as a stem cell marker in head and neck squamous cell carcinoma.
    Faber A; Barth C; Hörmann K; Kassner S; Schultz JD; Sommer U; Stern-Straeter J; Thorn C; Goessler UR
    Oncol Rep; 2011 Aug; 26(2):321-6. PubMed ID: 21617876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BMP-2 expression correlates with local failure in head and neck squamous cell carcinoma.
    Sand JP; Kokorina NA; Zakharkin SO; Lewis JS; Nussenbaum B
    Otolaryngol Head Neck Surg; 2014 Feb; 150(2):245-50. PubMed ID: 24247005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of CD44 splice variants in squamous epithelia and squamous cell carcinomas of the head and neck.
    Herold-Mende C; Seiter S; Born AI; Patzelt E; Schupp M; Zöller J; Bosch FX; Zöller M
    J Pathol; 1996 May; 179(1):66-73. PubMed ID: 8691348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic importance of the expression of CD44 splice variants in oral squamous cell carcinomas.
    Stoll C; Baretton G; Soost F; Terpe HJ; Domide P; Löhrs U
    Oral Oncol; 1999 Sep; 35(5):484-9. PubMed ID: 10694948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased expression of cell adhesion genes in cancer stem-like cells isolated from primary oral squamous cell carcinomas.
    Mishra A; Sriram H; Chandarana P; Tanavde V; Kumar RV; Gopinath A; Govindarajan R; Ramaswamy S; Sadasivam S
    Tumour Biol; 2018 May; 40(5):1010428318780859. PubMed ID: 29888653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternation of β-catenin and CD44s Immunoexpression in Different Histopathological Grades of Oral Squamous Cell Carcinoma.
    Zargaran M
    Asian Pac J Cancer Prev; 2020 May; 21(5):1181-1185. PubMed ID: 32458620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HPV status, cancer stem cell marker expression, hypoxia gene signatures and tumour volume identify good prognosis subgroups in patients with HNSCC after primary radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG).
    Linge A; Lohaus F; Löck S; Nowak A; Gudziol V; Valentini C; von Neubeck C; Jütz M; Tinhofer I; Budach V; Sak A; Stuschke M; Balermpas P; Rödel C; Grosu AL; Abdollahi A; Debus J; Ganswindt U; Belka C; Pigorsch S; Combs SE; Mönnich D; Zips D; Buchholz F; Aust DE; Baretton GB; Thames HD; Dubrovska A; Alsner J; Overgaard J; Krause M; Baumann M;
    Radiother Oncol; 2016 Dec; 121(3):364-373. PubMed ID: 27913065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of p63 and CD44 in oral squamous cell carcinoma and correlation with clinicopathological parameters.
    Saghravanian N; Anvari K; Ghazi N; Memar B; Shahsavari M; Aghaee MA
    Arch Oral Biol; 2017 Oct; 82():160-165. PubMed ID: 28645102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of c-fos promotes cell invasion and migration via CD44 pathway in oral squamous cell carcinoma.
    Dong C; Ye DX; Zhang WB; Pan HY; Zhang ZY; Zhang L
    J Oral Pathol Med; 2015 May; 44(5):353-60. PubMed ID: 25482572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Site-specific gene expression patterns in oral cancer.
    Frohwitter G; Buerger H; Korsching E; van Diest PJ; Kleinheinz J; Fillies T
    Head Face Med; 2017 May; 13(1):6. PubMed ID: 28486965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycogen-Rich Clear Cell Squamous Cell Carcinoma Originating in the Oral Cavity.
    Khoury ZH; Bugshan A; Lubek JE; Papadimitriou JC; Basile JR; Younis RH
    Head Neck Pathol; 2017 Dec; 11(4):552-560. PubMed ID: 28342060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of E-cadherin, CD44s, and CD44v6 in laryngeal and pharyngeal carcinomas.
    Rodrigo JP; Dominguez F; Alvarez C; Herrero A; Suarez C
    Am J Otolaryngol; 2003; 24(6):384-9. PubMed ID: 14608570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.